At-Home Molecular Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031
상품코드:1624308
리서치사:Fairfield Market Research
발행일:2024년 12월
페이지 정보:영문 221 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 재택분자검사 시장 규모는 2024년 115억 5,000만 달러에서 2031년 말에는 170억 9,000만 달러로 성장할 것으로 예측되며 5.8%의 CAGR이 전망되고 있습니다. 개인 집에있는 동안 편리하게 사용할 수있는 분자진단 솔루션을 제공하는 데 중점을 둡니다.
집에서의 분자 검사는 사용하기 쉬운 진단 솔루션을 통해 적극적인 건강 관리를 가능하게 함으로써 건강 관리의 상황을 일변시키고 있습니다. 혜택을 받아 유전 검사 서비스에 대한 수요의 급증을 촉진하고 있습니다.
맞춤형 의료는 현대 건강 관리의 최전선에 있으며, 개인의 유전자 프로파일에 맞게 의료 개입을 실시합니다. 이를 위해 개별화 된 지식을 추구함에 따라 가정 분자 검사에 대한 수요를 촉진하고 있습니다.
소비자들은 건강에 대한 적극적인 접근법을 점점 채택하고 있으며, 충분한 정보를 바탕으로 라이프스타일과 헬스케어 결정을 할 수 있는 힘을 제공해 주는 사용하기 쉬운 진단 도구를 요구하고 있습니다. 집에서 간편하게 검사를 할 수 있는 것은 이와 같은 헬스케어 기호의 변화와 일치하고 있습니다.
본 보고서에서는 세계의 재택분자검사시장에 대해 조사했으며, 시장 개요와 함께 제품별, 샘플유형별, 검사유형별, 유통채널별, 지역별 동향 및 시장 진출기업의 경쟁동향 등을 제공합니다.
목차
제1장 주요 요약
제2장 시장 개요
시장 정의와 세분화
시장 역학
밸류체인 분석
Porter's Five Forces 분석
COVID-19의 영향 분석
우크라이나·러시아 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의 재택 분자 검사 시장 전망, 2019-2031년
세계의 재택 분자 검사 시장 전망, 제품별, 금액(10억 달러), 수량(킬로톤), 2019-2031년
세계의 재택 분자 검사 시장 전망, 샘플 유형별, 금액(10억 달러), 수량(킬로톤), 2019-2031년
세계의 재택 분자 검사 시장 전망, 검사 유형별, 금액(10억 달러), 수량(킬로톤), 2019-2031년
세계의 재택 분자 검사 시장 전망, 유통 채널별, 금액(10억 달러), 수량(킬로톤), 2019-2031년
세계의 재택 분자 검사 시장 전망, 지역별, 금액(10억 달러), 수량(킬로톤), 2019-2031년
제4장 북미의 재택 분자 검사 시장 전망, 2019-2031년
제5장 유럽의 재택 분자 검사 시장 전망, 2019-2031년
제6장 아시아태평양의 재택 분자 검사 시장 전망, 2019-2031년
제7장 라틴아메리카의 재택 분자 검사 시장 전망, 2019-2031년
제8장 중동 및 아프리카의 재택 분자 검사 시장 전망, 2019-2031년
제9장 경쟁 구도
검사 유형별 및 샘플 유형별 히트맵
제조업체별 샘플 유형별 히트 맵
기업의 시장 점유율 분석, 2023년
경쟁 대시보드
기업 프로파일
Abbott
ACON Laboratories, Inc.
Rapikit
Becton and Dickinson
Cardinal Health
B. Braun Melsungen AG
Piramal Enterprises Ltd.
Siemens Healthcare GmbH
Quidel Corporation
Bionime Corporation
SA Scientific
ARKRAY USA, Inc.
Nova Biomedical
AdvaCare Pharma
AccuBioTech Co., Ltd.
Atlas Medical UK
TaiDoc Technology Corporation
Dragerwerk AG & Co. KGaA
제10장 부록
JHS
영문 목차
영문목차
The global at-home molecular testing market is forecast to grow from $11.55 billion in 2024 to $17.09 billion by the end of 2031, reflecting a robust compound annual growth rate (CAGR) of 5.8%. This rapidly expanding sector focuses on providing molecular diagnostic solutions that individuals can conveniently use from the comfort of their homes. By analyzing genetic material such as DNA or RNA, these tests offer insights into health conditions, genetic predispositions, and familial ties.
At-home molecular testing is transforming the healthcare landscape by enabling proactive health management through accessible diagnostic solutions. The market benefits from advancements in molecular biology and the growing appeal of personalized medicine, which has encouraged a surge in demand for genetic testing services. With continuous technological progress, these tests are becoming more affordable and user-friendly, driving widespread adoption across diverse demographics.
Market Growth Drivers
1.The Personalized Medicine Boom
Personalized medicine is at the forefront of modern healthcare, tailoring medical interventions to an individual's genetic profile.
The rising awareness of the benefits of understanding genetic predispositions is fueling the demand for at-home molecular testing, as consumers seek personalized insights for proactive health management.
2.Consumer-Driven Proactive Health Management
Consumers are increasingly adopting a proactive approach to health, seeking accessible diagnostic tools that empower them to make informed lifestyle and healthcare decisions.
The ability to conduct tests conveniently at home aligns with this shift in healthcare preferences.
3.Advancements in Molecular Biology
Technological advancements have simplified molecular testing processes, enabling easier sample collection and submission.
These innovations are broadening the market appeal and accessibility of at-home testing solutions.
Market Restraints
1.Challenges in Ensuring Precision and Reliability
Ensuring the accuracy of test results outside a clinical environment remains a challenge.
The absence of professional oversight during sample collection raises concerns about potential inaccuracies.
2.Regulatory Hurdles
The lack of uniform regulatory frameworks for at-home molecular testing creates challenges for manufacturers.
Striking a balance between fostering innovation and ensuring consumer safety is a critical concern for regulatory bodies.
Opportunities
1.Integration of AI and Machine Learning
The adoption of Artificial Intelligence (AI) and Machine Learning (ML) in genetic data analysis offers transformative potential.
These technologies can identify patterns and correlations in genetic data, enabling more precise and personalized health insights.
2.Expanding Consumer Reach Through Digital Platforms
The growing prevalence of e-commerce and online pharmacies enhances accessibility to at-home molecular testing kits.
Companies can leverage digital marketing and distribution channels to tap into a global consumer base.
Regional Analysis
1.North America: The Leading Region
North America is set to dominate the global at-home molecular testing market, driven by its advanced healthcare infrastructure and consumer awareness of personalized healthcare solutions.
The region's strong regulatory framework, coupled with the presence of major industry players, supports market growth.
2.Asia Pacific: A Rapidly Growing Market
Asia Pacific is expected to witness the fastest growth, driven by increasing incidences of chronic and infectious diseases in densely populated countries like China and India.
Rising disposable incomes, e-commerce growth, and demand for accessible healthcare solutions contribute to the region's market expansion.
Competitive Intelligence and Business Strategy
The at-home molecular testing market is highly competitive, with key players focusing on innovation, product differentiation, and strategic partnerships to strengthen their market positions.
Key Players Profiled
Abbott
ACON Laboratories, Inc.
Rapikit
Becton and Dickinson
Cardinal Health
B. Braun Melsungen AG
Piramal Enterprises Ltd.
Siemens Healthcare GmbH
Quidel Corporation
23andMe
MyHeritage
AncestryDNA
At-Home Molecular Testing Market Segmentation
1.By Product
Cassettes
Strips
Test Panels
Dip Cards
Midstream
Others
2.By Test Type
Pregnancy Tests
HIV Tests
Diabetes
Infectious Diseases
Glucose Tests
Ovulation Predictor Tests
Drug Abuse Tests
Others
3.By Sample Type
Urine
Blood
Saliva
Others
4.By Distribution Channel
Retail Pharmacies
Drug Stores
Supermarkets/Hypermarkets
Online Pharmacies
5.By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global At-Home Molecular Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global At-Home Molecular Testing Market Outlook, 2019 - 2031
3.1. Global At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Cassettes
3.1.1.2. Test Panels
3.1.1.3. Dip Cards
3.1.1.4. Midstream
3.1.1.5. Strips
3.1.1.6. Others
3.2. Global At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Urine
3.2.1.2. Blood
3.2.1.3. Saliva
3.2.1.4. Others
3.3. Global At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Pregnancy Tests
3.3.1.2. HIV Tests
3.3.1.3. Diabetes
3.3.1.4. Infectious Diseases
3.3.1.5. Glucose Tests
3.3.1.6. Ovulation Predictor Tests
3.3.1.7. Drug Abuse Tests
3.3.1.8. Others
3.4. Global At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. Retail Pharmacies
3.4.1.2. Drug Stores
3.4.1.3. Supermarkets/Hypermarkets
3.4.1.4. Online Pharmacies
3.5. Global At-Home Molecular Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America At-Home Molecular Testing Market Outlook, 2019 - 2031
4.1. North America At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Cassettes
4.1.1.2. Test Panels
4.1.1.3. Dip Cards
4.1.1.4. Midstream
4.1.1.5. Strips
4.1.1.6. Others
4.2. North America At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Urine
4.2.1.2. Blood
4.2.1.3. Saliva
4.2.1.4. Others
4.3. North America At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Pregnancy Tests
4.3.1.2. HIV Tests
4.3.1.3. Diabetes
4.3.1.4. Infectious Diseases
4.3.1.5. Glucose Tests
4.3.1.6. Ovulation Predictor Tests
4.3.1.7. Drug Abuse Tests
4.3.1.8. Others
4.4. North America At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. Retail Pharmacies
4.4.1.2. Drug Stores
4.4.1.3. Supermarkets/Hypermarkets
4.4.1.4. Online Pharmacies
4.5. North America At-Home Molecular Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1.2. U.S. At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1.3. U.S. At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1.4. U.S. At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1.5. Canada At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1.6. Canada At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1.7. Canada At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
4.5.1.8. Canada At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
